| 1 -0.53 (-34.64%) | 06-12 13:53 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1.62  |
1-year : | 2.34 |
| Resists | First : | 1.39 |
Second : | 2 |
| Pivot price | 0.57  |
|||
| Supports | First : | 0.38 |
Second : | 0.32 |
| MAs | MA(5) : | 0.79 |
MA(20) : | 0.53 |
| MA(100) : | 0.7 |
MA(250) : | 1.07 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 61.2 |
D(3) : | 64.7 |
| RSI | RSI(14): 61.4 |
|||
| 52-week | High : | 2.11 | Low : | 0.38 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ GELS ] has closed below upper band by 15.1%. Bollinger Bands are 359% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 2.01 - 2.02 | 2.02 - 2.03 |
| Low: | 0.5 - 0.51 | 0.51 - 0.51 |
| Close: | 1.52 - 1.53 | 1.53 - 1.54 |
Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription remedies, nutritional supplements (including sports-related products), and veterinary care items.
Fri, 08 May 2026
What makes Gelteq Limited (GELS) a compelling holding for the long term (Hovering) 2026-05-08 - Percent Below MA - newsline.com
Tue, 05 May 2026
What Gelteq Limited (GELS) is doing that smarter investors notice (Institutional Selling) 2026-05-05 - Positive Gamma - newsline.com
Mon, 20 Apr 2026
Gelteq Limited (GELS) Stock Bracket Order (Smart Money Active) 2026-04-20 - Zigzag Correction - The Legal Advocate
Thu, 09 Apr 2026
What support levels matter for Gelteq Limited (GELS) Stock | Price at $0.75, Up 13.12% - Hagopian Line - newsline.com
Tue, 07 Apr 2026
Will Gelteq Limited (GELS) Stock Grow in 2026 | Price at $0.67, Down 4.86% - OBV Divergence - newsline.com
Mon, 06 Apr 2026
Is Gelteq Limited (GELS) Stock Moving Sideways | Price at $0.66, Down 3.09% - Wyckoff Distribution - The Legal Advocate
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 0 (M) |
| Shares Float | 11 (M) |
| Held by Insiders | 4.68e+006 (%) |
| Held by Institutions | 47.5 (%) |
| Shares Short | 57 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -3.84e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -2 % |
| Return on Assets (ttm) | 969.4 % |
| Return on Equity (ttm) | -15 % |
| Qtrly Rev. Growth | 413130 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -0.6 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 120950 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|